Emerging evidences indicate that EZH2 is indispensable for BCSC proliferation (61) and its specific silencing inhibits glioblastoma multiforme CSC self-renewal in vitro and tumor-initiating capacity in vivo (62). The gene discussed is EZH2; the disease is neoplasm.